|
|
Volumn 146, Issue 8, 2007, Pages 602-605
|
|
Linking cost sharing to value: An unrivaled yet unrealized public health opportunity
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTINEOPLASTIC AGENT;
ANTIRETROVIRUS AGENT;
ANTIVIRUS AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
BUPRENORPHINE;
CORTICOSTEROID DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FAMCICLOVIR;
HORMONE ANTAGONIST;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW MOLECULAR WEIGHT HEPARIN;
NICOTINE;
PNEUMOCOCCUS VACCINE;
PROTON PUMP INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
VALACICLOVIR;
ASTHMA;
BREAST CANCER;
CLINICAL PRACTICE;
CORRELATION ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DEVELOPED COUNTRY;
DIABETES MELLITUS;
EMPIRICISM;
FINANCIAL MANAGEMENT;
GASTROESOPHAGEAL REFLUX;
HEALTH CARE COST;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH CARE UTILIZATION;
HEALTH SERVICE;
HEART INFARCTION;
HEPATITIS C;
HERPES ZOSTER;
HIP FRACTURE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERTENSION;
MAJOR DEPRESSION;
MORALITY;
MORBIDITY;
MORTALITY;
OBSERVATIONAL STUDY;
OPIATE ADDICTION;
PATIENT CARE;
PRIORITY JOURNAL;
PROPHYLAXIS;
PUBLIC HEALTH SERVICE;
REVIEW;
STREPTOCOCCUS INFECTION;
TOBACCO DEPENDENCE;
UNITED STATES;
VENOUS THROMBOEMBOLISM;
ARTICLE;
COST;
COST BENEFIT ANALYSIS;
ECONOMICS;
PUBLIC HEALTH;
STANDARD;
COST SHARING;
COST-BENEFIT ANALYSIS;
HEALTH SERVICES;
HEALTH SERVICES MISUSE;
HUMANS;
PUBLIC HEALTH;
UNITED STATES;
|
|
EID: 34247586802
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-146-8-200704170-00011 Document Type: Review |
|
Times cited : (28)
|
|
References (20)
|
